FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a composition for local application containing the enzyme ribonuclease and stearyl glycyrrhetinate or a glycyrrhetinic acid or a salt thereof: ammonium or dipotassium or trisodium glycyrrhizinate, and acceptable carriers or excipients to be used in medicine for treating and preventing viral infections.
EFFECT: invention provides preparing the stable compositions maintaining the enzymatic activity for five years.
1 cl, 7 ex, 1 tbl
Authors
Dates
2013-12-20—Published
2012-10-25—Filed